Preventable Vaccines Market
Preventable Vaccines Market Size, Share & Trends Analysis Report
Preventable Vaccines Market Size, Share, Statistics & Trends Analysis Report By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Polio, Hepatitis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Based On Region, And Segment Forecasts, 2022 – 2029
Published
Report ID : BMRC 2295
Number of pages : 300
Published Date : Jan 2023
Category : Vaccines
Delivery Timeline : 48 hrs
Key Players:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Bharat Biotech (India)
- Serum Institute of India Pvt. Ltd (India)
- EMERGENT (U.S.)
Segmentations:
By Technology
- Inactivated Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Others
By Indication
- Pneumococcal Disease
- Influenza
- Polio
- Hepatitis
- Others
By Route of Administration
- Oral
- Parenteral
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
SUMMARY
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
